Dynamic copy choice: Steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching

Por Hwang, Carey K., Svarovskaia, Evguenia S., Pathak, Vinay K.
Publicado em 2001

Development of an In Vivo Assay To Identify Structural Determinants in Murine Leukemia Virus Reverse Transcriptase Important for Fidelity

Por Halvas, Elias K., Svarovskaia, Evguenia S., Pathak, Vinay K.
Publicado em 2000

Role of Murine Leukemia Virus Reverse Transcriptase Deoxyribonucleoside Triphosphate-Binding Site in Retroviral Replication and In Vivo Fidelity

Por Halvas, Elias K., Svarovskaia, Evguenia S., Pathak, Vinay K.
Publicado em 2000

Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine–thymine tracts

Por Zhang, Wen-Hui, Svarovskaia, Evguenia S., Barr, Rebekah, Pathak, Vinay K.
Publicado em 2002

Wild-Type and YMDD Mutant Murine Leukemia Virus Reverse Transcriptases Are Resistant to 2′,3′-Dideoxy-3′-Thiacytidine

Por Halvas, Elias K., Svarovskaia, Evguenia S., Freed, Eric O., Pathak, Vinay K.
Publicado em 2000

Structural Determinants of Murine Leukemia Virus Reverse Transcriptase That Affect the Frequency of Template Switching

Por Svarovskaia, Evguenia S., Delviks, Krista A., Hwang, Carey K., Pathak, Vinay K.
Publicado em 2000

Antiretroviral Drug Resistance Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Template-Switching Frequency

Por Nikolenko, Galina N., Svarovskaia, Evguenia S., Delviks, Krista A., Pathak, Vinay K.
Publicado em 2004

Allele-Specific Real-Time PCR System for Detection of Subpopulations of Genotype 1a and 1b Hepatitis C NS5B Y448H Mutant Viruses in Clinical Samples

Por Bae, Andrew S., Ku, Karin S., Miller, Michael D., Mo, Hongmei, Svarovskaia, Evguenia S.
Publicado em 2011

Abundant Drug-Resistant NS3 Mutants Detected by Deep Sequencing in Hepatitis C Virus-Infected Patients Undergoing NS3 Protease Inhibitor Monotherapy

Por Svarovskaia, Evguenia S., Martin, Ross, McHutchison, John G., Miller, Michael D., Mo, Hongmei
Publicado em 2012

Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6

Por Ku, Karin S., Chodavarapu, Ramakrishna K., Martin, Ross, Miller, Michael D., Mo, Hongmei, Svarovskaia, Evguenia S.
Publicado no J Clin Microbiol (2016)

A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion

Por Xu, Hongzhan, Svarovskaia, Evguenia S., Barr, Rebekah, Zhang, Yijun, Khan, Mohammad A., Strebel, Klaus, Pathak, Vinay K.
Publicado em 2004

MultiCode-RTx Real-Time PCR System for Detection of Subpopulations of K65R Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant Viruses in Clinical Samples

Por Svarovskaia, Evguenia S., Moser, Michael J., Bae, Andrew S., Prudent, James R., Miller, Michael D., Borroto-Esoda, Katyna
Publicado em 2006

Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus

Por Hedskog, Charlotte, Chodavarapu, Krishna, Ku, Karin S., Xu, Simin, Martin, Ross, Miller, Michael D., Mo, Hongmei, Svarovskaia, Evguenia
Publicado no J Clin Microbiol (2015)

Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885

Por Wong, Kelly A., Worth, Angela, Martin, Ross, Svarovskaia, Evguenia, Brainard, Diana M., Lawitz, Eric, Miller, Michael D., Mo, Hongmei
Publicado em 2013

Azido-Containing Diketo Acid Derivatives Inhibit Human Immunodeficiency Virus Type 1 Integrase In Vivo and Influence the Frequency of Deletions at Two-Long-Terminal-Repeat-Circle J...

Por Svarovskaia, Evguenia S., Barr, Rebekah, Zhang, Xuechun, Pais, Godwin C. G., Marchand, Christophe, Pommier, Yves, Burke, Terrence R., Pathak, Vinay K.
Publicado em 2004

The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study

Por Feng, Joy Y, Ly, John K, Myrick, Florence, Goodman, Derrick, White, Kirsten L, Svarovskaia, Evguenia S, Borroto-Esoda, Katyna, Miller, Michael D
Publicado em 2009

A classification model for G-to-A hypermutation in hepatitis B virus ultra-deep pyrosequencing reads

Por Reuman, Elizabeth C., Margeridon-Thermet, Severine, Caudill, Harrison B., Liu, Tommy, Borroto-Esoda, Katyna, Svarovskaia, Evguenia S., Holmes, Susan P., Shafer, Robert W.
Publicado em 2010

Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance

Por Powdrill, Megan H., Tchesnokov, Egor P., Kozak, Robert A., Russell, Rodney S., Martin, Ross, Svarovskaia, Evguenia S., Mo, Hongmei, Kouyos, Roger D., Götte, Matthias
Publicado em 2011

Relationship between Minority NNRTI Resistance Mutations, Adherence, and the Risk of Virologic Failure

Por Li, Jonathan Z., Paredes, Roger, Ribaudo, Heather, Svarovskaia, Evguenia S., Kozal, Michael J., Hullsiek, Katherine Huppler, Miller, Michael D., Bangsberg, David, Kuritzkes, Daniel R.
Publicado em 2012

Clinical and In Vitro Resistance to GS-9669, a Thumb Site II Nonnucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase

Por Dvory-Sobol, Hadas, Voitenleitner, Christian, Mabery, Eric, Skurnac, Taylor, Lawitz, Eric J., McHutchison, John, Svarovskaia, Evguenia S., Delaney, William, Miller, Michael D., Mo, Hongmei
Publicado no Antimicrob Agents Chemother (2014)